MBX Share Price

Open 0.36 Change Price %
High 0.36 1 Day -0.02 -5.26
Low 0.35 1 Week -0.03 -7.69
Close 0.36 1 Month 0.05 16.13
Volume 37500 1 Year 0.13 56.52
52 Week High 0.40
52 Week Low 0.18
MBX Important Levels
Resistance 2 0.37
Resistance 1 0.37
Pivot 0.36
Support 1 0.35
Support 2 0.35
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
CVE 12.44 8.36%
CVE 12.44 8.36%
CVE 12.44 8.36%
TBE 0.03 0.00%
ECA 13.69 4.50%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
GGA 0.08 14.29%
CUM 0.90 13.92%
CUM 0.90 13.92%
DNT 0.10 11.11%
More..
TSE Canada Top Losers Stocks
HE 0.02 -33.33%
HE 0.02 -33.33%
GBV 0.46 -24.59%
GLG 0.94 -16.07%
CTU-A 0.19 -9.52%
RN 0.10 -9.09%
RN 0.10 -9.09%
BU 0.77 -8.33%
EFL 1.30 -7.14%
DEJ 0.14 -6.67%
More..

Microbix Biosystems (TSE: MBX)

MBX Technical Analysis 3
As on 20th Sep 2017 MBX Share Price closed @ 0.36 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.27 & Buy for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
MBX Target for September
1st Target up-side 0.4
2nd Target up-side 0.43
3rd Target up-side 0.47
1st Target down-side 0.3
2nd Target down-side 0.27
3rd Target down-side 0.23
MBX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.microbix.com
MBX Address
MBX
265 Watline Avenue
Mississauga, ON L4Z 1P3
Canada
Phone: 905-361-8910
Fax: 905-361-8911
MBX Latest News
Interactive Technical Analysis Chart Microbix Biosystems ( MBX TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Microbix Biosystems
MBX Business Profile
Microbix Biosystems Inc., a biotechnology company, develops, manufactures, and sells biological products and technologies in North America, Europe, and internationally. The company provides cell culture based infectious disease products; and licenses cell culture based technologies, as well as is involved in the contract development work in microbiology. It also offers infectious disease antigens, such as viral, bacterial, and parasitic products used in various applications, including immunodiagnostic assays; basic and applied research in virology, microbiology, cell biology, molecular biology, immunology, and pathology; as controls and calibrators for a range of medical devices; and for vaccine and antiviral research and development. In addition, the company provides adenovirus vectors, cells, and services to biopharmaceutical and biotechnology researchers and companies. The company develops various biological technologies, including VIRUSMAX, a vaccine manufacturing technology; LumiSort, a semen sexing technology; and Kinlytic, a thrombolytic drug. It serves medical diagnostic and biotechnology industries. The company was founded in 1988 and is headquartered in Mississauga, Canada.